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Geographic Biases in Human Lyme disease Surveillance and Utility of Companion Animal 
Sentinel Programs: Exploratory Spatial Analysis 
Brian Hendricks 
Background and Objectives: Mapping and exploratory spatial data analyses are ideal tools for 
characterizing spread and occurrence of human Lyme disease infection. Unfortunately, many 
mapped displays utilizing Lyme disease surveillance data are prone to bias due to a lack of 
consideration for geographical confounders. The objectives of our study were to 1) characterize 
the geographic effects that boundary and travel related biases have on visualization of human 
Lyme disease occurrence and 2) apply these findings to develop a more precise methodology for 
evaluating efficacy of animal sentinel surveillance programs in predicting incidence of human 
Lyme disease infection.  
Methods: County-level human Lyme disease and companion animal tick surveillance data were 
obtained from relevant state health departments. Data were organized within Microsoft Excel 
spreadsheets, and sorted by relevant reporting year and county. In Study 1, boundary effects 
were evaluated for the region containing Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and 
West Virginia 2010-2014, utilizing a combination of rate smoothing and local indicators of 
spatial autocorrelation. Trends in disease clustering over time within our multistate region were 
evaluated utilizing logistic generalized estimating equations. In Study 2, travel associated biases 
were evaluated only for West Virginia confirmed Lyme disease cases 2011-2015, utilizing a 
combination of paired t-test, Wilcoxon Rank Signed test, and local indicators of spatial 
autocorrelation. In Study 3, the efficacy of the companion animal (dog and cat) sentinel 
surveillance program in West Virginia 2014-2016, was evaluated utilizing a combination of 
ordinary least squares and spatial regression techniques as well as local indicators of spatial 
autocorrelation on regression residuals. 
Results: Study 1. Analyses indicated statistically significant (P = 0.05) clustering of human 
Lyme disease incidence over time. High-high clusters aggregated near counties bordering high 
incidence states, while low-low clusters aggregated near shared county borders in non-high 
incidence states. Study 2. Analyses indicated statistical non-equivalency using paired t-test (t = 
3.99, df = 54, P = 0.0002) and the non-parametric Wilcoxon Signed Rank test (S=264, P < 0.001) 
between total overall cases and those obtained within patient’s home county, suggesting 
significant travel-associated bias. Additionally, local indicators of spatial autocorrelation 
detected statistically significant (P = 0.05) patterns of clustering in the county level proportion of 
cases attributable to travel. Study 3. Regression analyses identified significant associations 
between confirmed cases of human Lyme disease and average number of Ixodes scapularis 
removed from dogs (ordinary least squares (β=0.20 P < 0.001) and spatial lag  (β = 0.12, P = 
0.002) models) but not cats for the period 2014-2016. Local indicators of spatial autocorrelation 
produced for spatial lag regression residuals indicated a decrease in model over and 
 
underestimation, but identified a higher number of statistically significant outliers than ordinary 
least squares regression.  
Conclusions: Results of spatial and regression analyses 1) indicate significant differential 
clustering of incident human Lyme disease within WV and surrounding states over time; 2) 
suggest substantial travel-associated bias in Lyme disease case visualization within WV; and 3) 
strongly support the use of companion animal, and specially dog sentinel surveillance programs 
for estimation of human Lyme disease risk within WV.  These findings suggest that geographic 
biases significantly affect visualization of human Lyme disease incidence and support the 
effectiveness of utilizing dogs as sentinel populations to estimate human risk. Findings of these 
three studies highlight the importance of using statistical methodologies that can accommodate 
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Lyme disease is the most common vectorborne disease in the United States (1, 2). Transmission 
of the etiological agent Borrelia burgderfori to humans is accomplished through the prolonged 
attachment of the eastern blacklegged tick Ixodes scapularis, or western blacklegged tick Ixodes 
pacificus (3, 4). Clinical diagnosis of Lyme disease within endemic areas is primarily guided by 
the manifestation of the EM rash following a seven day incubation period (5). However, up to as 
many as 20-30% of patients infected with Lyme disease do not display the characteristic rash 
potentially resulting in misdiagnosis (6, 7). If left untreated, patients can develop severe chronic 
multisystem conditions with limited treatment options (5, 8).  
Cases of human Lyme disease have been reported within every state of the contiguous United 
States (9), with two primary disease foci located in the Northeastern and North Central regions 
(10). Human case numbers vary dramatically by state, and often display a range of variable 
symptoms following infection (11, 12). As a result, criteria were established by Council of State 
and Territorial Epidemiologists to collect and analyze clinical, epidemiological, and laboratory 
diagnostic evidence within a national human Lyme disease surveillance system. Surveillance 
begins when potentially infected patients seek medical attention. Medical providers examine 
patients for physical manifestations of Lyme disease, and ask questions relating to exposure to 
tick habitat and recent travel history to ascertain probability of exposure (13). Physicians order 
diagnostic testing, which involves a screening test (ELISA or IFA), followed by a confirmatory 
test (IgG or IgM western blot) using the CDC approved two tier screening approach (13). This 
clinical, epidemiologic, and diagnostic evidence is then used to ascertain a case status 
(confirmed, probable, suspect, or not a case) to a patient (13).  
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Human exposure to Lyme disease is dependent on the overlapping distribution of ticks, hosts and 
favorable environmental factors described within the enzootic cycle of Lyme disease (14-16). 
Ticks become infected as nymphs or larvae after ingesting blood from reservoir hosts, such as 
white footed mice (Peromyscus leucopus). In the traditional enzootic cycle, blacklegged ticks are 
infected as larvae and carry the bacteria onto each of their successive life stages (17). The 
majority of human cases of Lyme disease are reported in the spring and early summer months 
during peak nymphal activity (16). In the fall, adult blacklegged ticks seek large mammalian 
hosts such as white tailed deer (Odocoileus virginianus) to locate other ticks for mating and to 
consume their final bloodmeal. Humans and other dead end hosts such as dogs, cats, and horses 
can also become infected (17, 18) in the fall following attachment of adult blacklegged ticks 
(16).   
Monitoring of enzootic transmission cycles for Lyme disease is inexact, as human exposure to 
infected ticks can vary depending on the climate, host availability, and tick specific diapause 
mechanisms (19).Uncertainty regarding the level of human exposure is further compounded by 
variability in Lyme disease reporting on a state by state basis (12). Public health researchers have 
attempted to pair human and animal Lyme disease surveillance data with exploratory spatial data 
analyses (ESDA) to identify high-risk groups and provide a clearer understanding of human risk. 
Common ESDA approaches used in public health include disease mapping, cluster analyses, and 
ecological analysis (20). Disease mapping applies statistical approaches to remove excess spatial 
variation from incidence maps (20-22). Ecological analyses investigate associations between the 
geographic distribution of disease incidence and potential explanatory factors (20, 23, 24). 
Disease clustering assesses the presence of abnormal aggregations of disease cases within 
mapped surveillance data (20, 21, 23). Together these approaches form the foundation of 
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exploratory spatial data analysis (ESDA) and provide a pathway to more complex modelling 
approaches (25).  
Mapping is one of the most widely used types of graphical displays applied to surveillance data 
(23). However generalization of this technique among untrained users often results in inaccurate 
interpretation of mapped data (26, 27). Communicating map information in an interpretable and 
representative fashion is often complicated by cartographic principles such as scale, 
symbolization, and the need for further processing (27, 28). The map’s scale dictates the extent 
to which data are averaged across the study area (28). Inappropriate choice of scale can mask or 
distort true geographic associations (22, 29). Likewise, in choosing semiotic display in maps, 
particular elements of the data are emphasized, while others are obscured or completely 
discarded (30). Lack of further processing is a common conceptual problem resulting from 
unavailability of data in the form most efficient for interpretation (28). Together these principles 
influence perception of mapped surveillance data. For example, incidence of disease is often 
displayed within thematic maps containing multiple predefined classes and color schemes. 
Audiences are left to their own conclusions regarding the maps overall message depending on 
the chosen color scheme and the range of values within the defined classes. These individualistic 
interpretations are potentially prone to biases without complementary statistical information (28).  
Exploratory spatial analyses have been applied to investigate spatial trends in human and animal 
Lyme disease surveillance data. Findings focused on human surveillance data describe potential 
clustering and temporal trends in visualization of Lyme disease incidence (10, 31, 32), and 
varying model reliability between wild caught ticks and human infection by locality (33). While 
previous animal ESDA research explore associations between serosurveys and tick collections 
among dogs and human Lyme disease incidence (34-36). Findings indicated that boundary 
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effects and travel-associated infections potentially bias mapped representations of human 
incidence (20, 33, 37-39) and that companion animals such as dogs are useful indicators of high-
risk for human populations (36, 40). However, studies that adjust for potential geographic biases 
in human studies, that incorporate analysis of time trends, and that adjust for spatial dependence 
or consider model efficacy in animal surveillance studies remain sparse. Consequently, the 
underlying spatial processes influencing the occurrence of human cases and the distribution of 
infected ticks and hosts remain obscured, resulting in potentially inaccurate representations of 
true human Lyme disease risk.  
To accommodate spatial structure within public health Lyme disease surveillance data and fill 
current gaps in knowledge, we have developed a series of three complementary studies. The first 
study examines human Lyme disease reporting on a regional level and incorporates ESDA rate 
smoothing approaches to mitigate boundary effects. Controlling for boundary effects reduces the 
influence extreme differences in state level Lyme disease incidence have on accurate 
representation of county-level human Lyme disease risk. The second study evaluates travel-
associated disease acquisition as a potentially important source of bias in visualization of human 
Lyme disease surveillance data in West Virginia and identifies spatial patterns in the proportion 
of cases attributable to travel among confirmed human Lyme disease cases. Our final 
investigation utilizes ordinary least squares and spatial regression models to identity significant 
associations between Ixodes scapularis companion animal collections and human Lyme disease 
incidence in West Virginia. We incorporate our research findings from the first two studies by 
removing travel-associated cases and adjusting for spatial dependence in county level human 
Lyme disease incidence. Additionally we evaluate model efficacy utilizing a combination of 
traditional and spatial model selection techniques. Together, these studies address important gaps 
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Using Exploratory Data Analysis to Identify and Predict Patterns of Human Lyme Disease 
Case Clustering within a Multistate Region, 2010-2014 
 
ABSTRACT 
Lyme disease is the most commonly reported vectorborne disease in the United States. The 
objective of our study was to identify patterns of Lyme disease reporting after multistate 
inclusion to mitigate potential border effects. County-level human Lyme disease surveillance 
data were obtained from Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia 
state health departments. Rate smoothing and Local Moran’s I was performed to identify clusters 
of reporting activity and identify spatial outliers.  A logistic generalized estimating equation was 
performed to identify significant associations in disease clustering over time. Resulting analyses 
identified statistically significant (P=0.05) clusters of high reporting activity and trends over 
time. High reporting activity aggregated near border counties in high incidence states, while low 
reporting aggregated near shared county borders in non-high incidence states. Findings highlight 
the need for exploratory surveillance approaches to describe the extent to which state level 
reporting affects accurate estimation of Lyme disease progression.  









Lyme disease is the most common vectorborne disease in the United States with an estimated 
300,000 new individuals effected annually (1, 2). Acute human infection is typically associated 
with one or more erythema migrans (EM) (bull’s eye rash), arthritis, and to a lesser extent Lyme 
carditis or neuroborreliosis (3). While early antibiotic therapy is effective in up to 90% of 
diagnosed patients (4), approximately 20-30% of patients do not exhibit an EM rash 
complicating early diagnosis (5, 6). As a result, many possible human Lyme infections are 
misdiagnosed or left untreated, potentially resulting in chronic debilitating multisystem 
conditions with limited treatment options (3, 7).  
Human Lyme disease infection has been reported from every state in the United States except 
Hawaii (8). State level case counts include both locally acquired and travel associated. In recent 
years there has been an increasing trend in Lyme disease case reporting; case counts vary by 
state, and are thought to be associated with increasing abundance and changing distributions of 
tick vectors (9). This increase in the number of human infections paired with changing native 
tick populations emphasize the need for sustainable surveillance strategies focused on targeted 
prevention and early disease recognition and treatment programs (10).  
Exploratory spatial data analysis (ESDA) is one such strategy, allowing analysts the ability to 
explore data in terms of space and time. Common ESDA techniques used in public health 
include raw and spatial rate smoothing as well as cluster analysis (11-14). Spatial rate smoothing 
can be used to increase interpretability of disease maps by adjusting for variations in rate 
estimation (7). Cluster analyses are employed to investigate whether disease occurred by random 
chance, and understand directionality of disease expansion (7).  
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These techniques are ideal Lyme disease surveillance tools because of the inherent spatial 
processes that drive human pathogen transmission (15). Infected ticks must be in close spatial 
proximity to humans for transmission to occur. Previous studies have employed ESDA to 
visualize rates of human Lyme disease and identify pockets of high disease intensity. The 
authors found that cases of Lyme disease appeared to cluster near or at state lines, and believed 
this to be the result of misdiagnosis, disproportionate presence of infected ticks, or travel 
associated infections (7, 13, 14, 16, 17). These possible explanations are supported by previous 
work which describe the distribution of Lyme disease between states as dynamic, and 
specifically identify travel as potential source for ~80% of cases reported within low incidence 
states (9, 18). 
The region of the United States that includes the Midwest, Mid-Atlantic, and Southeastern states 
of Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia is an ideal study area 
to characterize Lyme disease case reporting near or at state lines.  High incidence states within 
the region include Maryland, Pennsylvania, and Virginia, all of which are in the top 15 states that 
report Lyme in the nation (19). Alternatively, Kentucky, Ohio, and West Virginia are in the mid 
to low range for Lyme disease incidence, but are bordered by one or more of the high incidence 
states within our study region (19). To date no known study has described the impact multistate 
inclusion has on geographic visualization of Lyme disease incidence within a region, as opposed 
to a state by state basis. The objective of our study was to identify patterns of Lyme disease 
reporting after multistate inclusion to mitigate potential border effects. 
METHODS 
Data Acquisition and Management 
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County-level probable and confirmed human Lyme disease surveillance data for 2010-2014 were 
obtained from the state health departments in West Virginia, Virginia, Ohio, Pennsylvania, 
Kentucky, and Maryland. Complete annual case totals were received from all states except for 
Kentucky, which had reporting data from 2012-2014. Surveillance data used in our analysis were 
limited to confirmed and probable case counts as those are what are nationally reported. Data 
were specifically requested from 2010-2014 to incorporate stricter diagnostic criteria within 
2008 and 2011 Lyme case definitions (7). Utilizing stricter criteria for case ascertainment led to 
increased consistency of medical, laboratory, and epidemiologic evidence among reported cases. 
Lyme disease case classification standards at each of the respective state health departments 
within the region were based on the current Council of State and Territorial Epidemiologist Case 
Definition for Lyme disease (20). A decision diagram is presented in Figure 1.1 to summarize 
current Lyme disease case classification criteria (21).  
Data were sorted in Microsoft Excel 2010 by state, county, and reporting year. Confirmed and 
probable Lyme disease case reports were paired with U.S. census county level population 
estimates by year and county (22). Excel spreadsheets containing the county level case 
information and population census data were joined within ArcGIS 10.1 (ESRI, Redlands CA) to 
a United States Counties and Localities shapefile obtained from U.S. Department of Agriculture 
National Resources Conservation Service Geospatial Gateway (USDA: NRCS) (23). The newly 
joined features were exported as a shapefiles and analyzed in GeoDa 1.6 (GeoDa Center, Tempe, 
AZ).  
Descriptive analysis 
Crude yearly estimated incidence rates were initially visualized to display variation in raw data. 
Estimated incidence by county was calculated by dividing the total number of confirmed and 
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probable Lyme disease cases by the respective county’s yearly July 1rst census estimates. Spatial 
weight connectivity histograms were constructed to characterize the distribution of neighbor 
structures for rook and queen spatial weights (24). Rook spatial weights characterize polygons 
which share a common border as neighbors, while queen spatial weights characterize all 
polygons which share a common border or vertex as neighbors. Typically, this difference results 
in a stricter neighbor criterion when rook spatial weights are applied. However, distribution of 
neighbors among contiguity weights in our study were almost identical, as a result the rook 
spatial weight was chosen due to the inconsistent size of counties within the region (13, 25).  
Smoothing techniques were applied to adjust crude incidence rates and reduce potential spurious 
outliers and biases (16). Adjusted yearly estimated incidence were calculated from the raw data 
after applying our rook spatial weight using Spatial Empirical Bayesian techniques to account for 
maximum localized instability of Lyme disease reporting rates among neighboring counties (26, 
27). Raw and adjusted yearly estimated incidence rates were expressed in terms of cases per 
100,000 persons using a quantile classification system with five groupings (0, 4, 20, 60, and >60 
cases per 100,000 persons) within ArcGIS 10.1. Incidence rates were classified this way to place 
specific emphasis on areas with low to moderate occurrence of Lyme disease.  
Cluster Analysis 
Local Empirical Bayesian Moran’s I estimates incorporating our previously defined rook spatial 
weight were conducted for each year independently by setting yearly annual total case count and 
yearly population census estimates as event and base variables respectively. Resulting Moran’s I 
scatterplots and local indicators of spatial autocorrelation (LISA) cluster maps with Empirical 
Bayesian rates were permuted 99,999 times at a pseudo p-value of 0.05 to optimize sensitivity of 
clustering and detection of statistically significant outliers while accounting for instability of 
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population at risk for each year within the region (26, 28, 29). A generalized estimating equation 
(GEE) were calculated in SAS 9.4 (SAS Institute Inc., Cary NC) with a logit link, binomial 
distribution, and repeated measures statement to describe any significant relationships between 
clusters of high reporting activity and time. Our GEE model excluded counties within Ohio and 
Kentucky because there were no high-high clusters identified for any of the years within our 
study period.  
RESULTS 
Descriptive analysis 
Overall from 2010-2014, 41,922 confirmed and probable Lyme disease cases were reported with 
0.25% (n=103) in Kentucky, 17.1% (n=7,186) in Maryland, 0.90% (n=375) in Ohio, 66% 
(n=27,591) in Pennsylvania, 14.4% (n=6,031) in Virginia, and 1.52% (n=636) in West Virginia 
(Table 1.1). Yearly estimated incidence for states included within the region ranged from 17.1-
23.3 per 100,000 persons. Among non-high incidence states, West Virginia had the highest 
estimated incidence of Lyme disease (5.22-7.34 per 100,000 persons), and accounted for only 
4.14-4.64% of the regions estimated population. Alternatively, Ohio accounted for 25.8-28.9% 
of the regions estimated population, but only had an estimated incidence of 0.38-1.03 per 
100,000 persons. Among the region’s high incidence states, Pennsylvania had the highest 
estimated incidence of Lyme disease (29.9-58.9 per 100,000 persons) and accounted for the 
highest proportion of the regions estimated population (28.5-35.1%). While Maryland accounted 
for a lower proportion of individuals in high incidence states than Virginia (13.0-14.5% versus 




County-level Lyme disease incidence per 100,000 persons for each state included within our 
study region is displayed in Figure 1.2. Variation in county-level incidence was reduced 
following Spatial Empirical Bayesian (SEB) rate, particularly in counties where the population at 
risk was smaller (Figure 1.3). Yearly proportion of counties within the region with no reported 
cases of Lyme disease decreased from 45-55% to 8-24%. Alternatively, a smaller effect was seen 
in counties which reported a yearly incidence of > 60 cases per 100,000 persons (11.7-15.2% vs 
11.7-13.8%). Despite this decrease, West Virginia counties of Berkeley, Hampshire, Jefferson, 
and Morgan remained the only counties to report an incidence of > 60 cases per 100,000 persons 
within a non-high incidence state in our study region. 
Cluster analysis 
Local Empirical Bayesian Moran’s I estimates of spatial autocorrelation for 2010-2014 were 
significant (P =0.05) for each year, and ranged from 0.18 to 0.30. High-high clusters were 
identified in Maryland, Pennsylvania, Virginia, and the eastern panhandle of West Virginia 
(Figure 1.4). Alternatively, low-low clusters of Lyme reporting were identified in Kentucky, 
Ohio, south western Virginia, and West Virginia (Figure 1.4). Spatial outliers (low-high) (n=30) 
were identified in Maryland, Pennsylvania, Virginia, and West Virginia during the study period. 
Overall, the number of counties regarded as hot spots (high-high) increased over time, while cold 
spots (low-low), and statically significant spatial outliers (low-high) fluctuated depending on 
year (Figure 1.5). Generalized estimating equations (GEE) were used to assess the trend of 
increasing high-high clusters over time from 2010-2014. The fitted model shows that there is a 
significant trend (increasing frequency of clusters over time) with OR = 1.29 (P < 0.001). An 




While spatial analyses have been used for some time in relevant literature, this is one of few 
studies to apply spatial analysis on a multistate scale to adjust for reporting activity in 
neighboring states. Additionally, this is the first known study to characterize county-level Lyme 
case clustering within Kentucky, Ohio, and West Virginia. Among states included, Kentucky had 
the lowest number of Lyme disease cases reported (14 to 45), while Pennsylvania had the highest 
(3,806 to 7,487). The greatest proportion of the multistate region’s population resided in 
Pennsylvania (28.5 to 31.8%), while the smallest proportion resided in West Virginia (4.14 to 
4.64%). Incidence rate visualization per 100,000 persons (Figures 1.2-1.3) revealed high 
reporting activity in the east and low reporting in the west. Both raw and smoothed rate 
visualization highlight the decreasing trend over time for counties with no reported cases of 
Lyme disease in the western part of the multistate region, excluding the increase within West 
Virginia and Ohio 2011-2012. However, smoothed incidence maps display reduced variability in 
county-level reporting among neighboring counties, and displayed fewer counties with no Lyme 
disease surveillance data. LISA cluster maps (Figure 1.4) indicated an increasing frequency of 
high-high counties observed over time in the eastern part of the multistate region with particular 
emphasis in the southwestern corner of Virginia and northeastern panhandle of West Virginia. 
This increase over time in high reporting activity within the multistate region is visualized in 
Figure 1.5 as the proportion of counties having high-high report clustering over time. Graphical 
representation of clustering within the region was displayed as a proportion of the total available 
county data due to lack of county level Lyme disease case data for Kentucky, 2010-2011. 
Subsequent GEE logistic analysis further supported our findings indicating increasing odds of 
county level high-high clustering over our study period within those states which had at least one 
high-high cluster identified in the LISA cluster map.  
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Study findings are based on a multistate exploratory spatial analysis of county level human Lyme 
disease case data. It is important to consider that while ESDA is particularly suited for 
identifying patterns of disease, it does not have the ability to explain the observed patterns (13). 
Other potential limitations associated with the use of surveillance data are linked to differential 
reporting biases which may potentially result in under or over reporting (30). Possible sources of 
differential reporting bias are varying presentations of Lyme disease signs and symptoms among 
infected patients, varying interpretations of the Lyme disease case definitions and unequal Lyme 
disease awareness among physicians and public health professionals (5, 6, 31). We attempt to 
adjust for varying interpretations of Lyme case definitions by limiting data acquisition to 2010-
2014, a period in which Lyme case definitions were most similar (20). Unfortunately, there was 
no way to control for varying levels of Lyme disease awareness or physician reported Lyme 
patient symptoms because of the aggregate and retrospective nature of our investigation.  
Despite these potential limitations, public health surveillance data provide valuable information 
in regards to Lyme disease occurrence, particularly in areas where pathogen prevalence among 
naturally occurring tick populations is rare or largely uncertain (32, 33). National Lyme disease 
surveillance data suggest a positive temporal association with cases of disease increasing over 
time with two prominent foci in the northeastern and north central United States (33, 34). 
Counties within these high incidence foci have continually expanded to now include localities 
within Maryland, Pennsylvania, Virginia, and West Virginia (33). This nationally observed trend 
is consistent with our study findings as well as studies conducted at the regional and state level, 
noting high reporting activity in Pennsylvania and Maryland as well as increasing frequency of 
high reporting clusters in Virginia (7, 35).   
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In general, epidemiologic patterns of human Lyme disease are largely dependent on tick-host 
environmental factors as well as human behaviors such as participation in outdoor activities, pet 
ownership, and travel (15, 36, 37). No human behavioral data were collected for any of the cases 
analyzed. However, spatial analysis did reveal clusters of high reporting activity near state lines 
in Maryland, Pennsylvania, Virginia, and West Virginia. This could suggest that travel history is 
important, particularly in non-high incidence states such as West Virginia, where Lyme ecology 
is largely undescribed. Unfortunately, there are a limited number of epidemiologic studies 
specifically focusing on Lyme disease occurrence in non-high incidence states. Exploratory 
spatial data analyses are particularly suited for public health professionals in these areas 
providing baseline risk assessment, and subsequent surveillance initiatives to illustrate spatio-
temporal changes in disease occurrence. Further research into the utility of spatial analysis for 
public health data is warranted, particularly in non-high incidence states where Lyme disease 
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Figure 1.1 Graphical Representation of Case Classification Criteria from the 2011 Council of State and 
Territorial Epidemiologists (CSTE) Lyme disease Case Definition. 
 
 




Table 1.1 Annual Human Lyme Disease Case Counts within our Multi State Region of 
Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia, 2010-2014. 
 
State Population (%) Case Investigations (%) Yearly Estimated Incidence  
(per 100,000) 
2010 
Region 39,922,622 6,836 17.1 
Kentucky - - - 
Maryland 5,787,193 (14.5%) 1,617 (23.7%) 27.9 
Ohio 11,545,435 (28.9%) 44 (0.64%) 0.38 
Pennsylvania 12,710,472 (31.8%) 3,805 (55.7%) 29.9 
Virginia 8,025,376 (20.1 ) 1,245 (18.2%) 15.5 
West Virginia 1,854,146 (4.64%) 125 (1.82%) 6.74 
2011 
Region 40,096,695 7,924 19.8 
Kentucky - - - 
Maryland 5,840,241 (14.6%) 1,351 (17.0%) 23.1 
Ohio 11,549,772 (28.8%) 53 (0.67%) 0.46 
Pennsylvania 12,741,310 (31.8%) 5,362 (67.7%) 42.1 
Virginia 8,110,188 (20.2%) 1,023 (12.9%) 12.6 
West Virginia 1,855,184 (4.63%) 135 (1.70%) 7.27 
2012 
Region 44,632,206 7,971 17.9 
Kentucky 4,379,730 (9.81%) 14 (0.17%) 0.32 
Maryland 5,884,868 (13.2%) 1,651 (20.7%) 28.1 
Ohio 11,553,031 (25.9%) 66 (0.83%) 0.57 
Pennsylvania 12,764,475 (28.6%) 5,033 (63.1%) 39.4 
Virginia 8,193,422 (18.4%) 1,110 (13.9%) 13.5 
West Virginia 1,856,680 (4.16%) 97 (1.22%) 5.22 
2013 
Region 44,793,367 8,685 19.4 
Kentucky 4,395,295 (9.81%) 44 (0.51%) 1.00 
Maryland 5,928,814 (13.2%) 1,194 (13.7%) 20.1 
Ohio 11,570,808 (25.8%) 93 (1.07%) 0.80 
Pennsylvania 12,773,801 (28.5%) 5,904 (68.0%) 46.2 
Virginia 8,270,345 (18.5) 1,307 (15.0%) 15.8 
West Virginia 1,854,304 (4.14%) 143 (1.65%) 7.71 
2014 
Region 44,531,085 10,387 23.3 
Kentucky 4,339,367 (9.74%) 45 (0.43%) 1.03 
Maryland 5,773,552 (13.0%) 1,373 (13.2%) 23.8 
Ohio 11,536,504 (25.9%) 119 (1.14%) 1.03 
Pennsylvania 12,702,379 (28.5%) 7,487 (72.1%) 58.9 
Virginia 8,326,289 (18.7%) 1,346 (13.0%) 16.2 
West Virginia 1,852,994 (4.16%) 136 (1.31%) 7.34 
** Population data are July 1rst mid-year population estimates from each year obtained from the U.S Census 
Bureau at the county level.  
** Annual Case counts are the sum of the confirmed and probable cases reported by each state’s respective 
state level health department. No case investigation data could be gathered from the Kentucky State Department 
of Health for 2010 and 2011. As a result population data for Kentucky are also excluded to make our 




Figure 1.2 Quantile Choropleth Maps Displaying Yearly Crude Incidence by County per 
100,000 Persons for Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia. 
No data are present for Kentucky from 2010-2011, due to data quality issues self-reported by 









Figure 1.3 Spatial Empirical Bayesian Smoothed Quantile Choropleth Maps Displaying 
Yearly Adjusted Incidence by County per 100,000 Persons for Kentucky, Maryland, Ohio, 
Pennsylvania, Virginia, and West Virginia. No data are present for Kentucky from 2010-2011, 
due to data quality issues self-reported by the Kentucky State Department of Health during 









Figure 1.4 Local Indicators of Spatial Autocorrelation (LISA) Cluster Analysis incorporating 
rook spatial weight, 99,999 permutations, and a pseudo p-value of 0.05 (Anselin 2003). 
Counties in dark grey are “hot spots” or high incidence counties surrounded by high incidence 
counties. Light grey counties are “cold spots” or low incidence counties surrounded by other 
low incidence counties. Counties in medium grey are statistically significant outliers or low 






Figure 1.5 Graphical Representation of the Proportion of County Level Lyme Reporting 
Hotspots (High-High), Cold Spots (Low-Low), and Statistically Significant Spatial Outliers 










































Local Indicators of Spatial Autocorrelation Results




Using Exploratory Spatial Data Analysis to Identify and Characterize Patterns of Travel 




Travel associated cases of Lyme disease are theorized to have a substantial effect on case 
visualization. Yet no study to date has formally focused on identifying the impact of travel 
related cases on geographic visualization of Lyme disease occurrence and spread. This study’s 
aims were to confirm travel as a source of geographic bias and 2) characterize spatial patterns 
associated with the proportion of cases attributable to travel using West Virginia Public health 
Lyme disease surveillance data. Confirmed cases were obtained for 2011-2015 from the West 
Virginia Bureau of Public Health. Following data preprocessing, variables representing total 
overall confirmed cases and only those cases obtaining infection within county of residence were 
visualized in separate maps and analyzed using a paired t-test. Spatial autocorrelation was 
assessed for the proportion of cases attributable to travel using a Local Moran’s I with empirical 
Bayesian rate. The paired t-test indicated statistically significant (t = 3.99, df = 54, P = 0.0002) 
non-equivalency between total overall cases and those obtained within patient’s home county. 
Local Moran’s I identified statistically significant autocorrelation (I = 0.17, pseudo P = 0.02) and 
both clusters and spatial outliers. Findings suggest that travel associated case acquisition is a 
significant source of geographic bias in visualization of Lyme disease cases. 







Lyme disease caused by human exposure to the bacterial agent Borrelia burgdorferi, is the most 
common vectorborne disease in the United States (1, 2). Human infection results in multi-
symptom conditions and can lead to serious health consequences if left untreated (3). While 
cases have been documented within each state of the contiguous U.S. (4), a proportion are 
regarded as travel-associated. The concept of travel associated Lyme disease cases was noted as 
early as 1979 (5) and has since been hypothesized as a source of confounding for case 
visualization (6, 7). The potential for confounding is exacerbated in low incidence areas where 
up to 80% of cases are potentially attributable to recent travel to high incidence areas (8). Yet, no 
study to date has confirmed that travel-associated Lyme disease cases is a confounding factor for 
spatial analysis within public health surveillance data. Consequently, this retrospective 
investigation aims to 1) establish travel as statistically significant source of geographical bias in 
visualization of Lyme disease surveillance data and 2) identify spatial patterns in the proportion 
of travel related cases reported in West Virginia.  
METHODS 
Confirmed human Lyme disease case counts for 2011-2015 were provided by the West Virginia 
Bureau of Public Health (9). This period was chosen because of similarities in Lyme disease case 
definitions, providing consistency among epidemiologic, medical, and laboratory evidence (10). 
The data contains variables for the patient’s home county, the reporting year, and a dummy 
variable indicating whether a case was travel-related. Criteria used by local health departments to 
designate cases as travel related are based upon the patient’s self-reported travel history and most 
likely location of tick exposure (11). Three county-level (n=55) variables were created using the 
travel-related disease attribute, representing total cases, cases infected within the patient’s home 
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county, and proportion of cases attributable to travel. Spreadsheets were joined in ArcMap 
(ESRI, Redlands CA) to a United States Counties and Localities shape file (12). Choropleth 
maps were created for total cases and those obtaining infection within their county of residence. 
County-level choropleth class breaks were set as 0, 1 to 4, 5 to 20, 21 to 60, and > 60 cases to 
place specific emphasis on counties with low to moderate occurrence of Lyme disease (6). A 
paired t-test and Wilcoxon Signed Rank test were conducted utilizing SAS 9.4 (SAS Institute, 
Cary NC) to determine if the county level differences between total overall confirmed Lyme 
disease cases and confirmed cases obtained within patient’s home county were statistically 
equivalent to zero. Univariate Local Moran’s I analyses with empirical Bayesian rate were 
conducted in GeoDa 1.8 (GeoDa Center, Tempe AZ) to identify spatial patterns, and adjust for 
instability of variances in rates calculated (13, 14). A queen’s contiguity matrix was used to 
identify neighbors in the local analysis, and results were permuted 99,999 times to detect 
statistically significant clustering and outliers at a pseudo p-value of 0.05 (15).  
RESULTS 
There were 660 confirmed Lyme disease cases in West Virginia from 2011-2015, of which 541 
(82%) were obtained within the patient’s home county. Statistically significant non-equivalency 
was identified in paired t-test (t = 3.99, df = 54, P = 0.0002) and Wilcoxon Signed Rank test (S = 
264, P < 0.001) among variables representing total overall confirmed cases of Lyme disease and 
those which obtained infection within their home county. The number of counties within each of 
the choropleth classes differed between inclusion or exclusion of travel related cases (Figure 
2.1). Univariate Local Moran’s I with empirical Bayesian rate detected statistically significant (I 
= 0.17, pseudo P = 0.02) clustering and spatial outliers (Figure 2.2). Counties ranked as high-
high have a high proportion of cases attributable to travel and border counties which on average 
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also have a high proportion of travel related cases. Conversely, low-low and low-high counties 
have a low proportion of cases attributable to travel which border counties with a low (low-low) 
or high (low-high) average proportion of travel related cases.  
DISCUSSION 
Travel is commonly mentioned as a potential source of bias in Lyme disease literature. West 
Virginia is an ideal state to study geographic biases associated with Lyme disease case reporting 
as it is a transitional state, bordered on the east by high incidence states of Maryland, Virginia, 
and Pennsylvania and on the west by low incidence states of Kentucky and Ohio (16). This is the 
first known study to employ statistical and spatial analytic methodologies to confirm the 
necessity of adjusting for travel associated cases within public health surveillance data prior to 
geographic visualization. Adjustment for travel resulted in statewide changes in the number of 
counties represented within each of the choropleth classes (Figure 2.1). In particular, the 
choropleth classes with zero, 1 to 4, and 5 to 20 confirmed Lyme disease cases displayed 
dramatic (± 16-50%) changes in the percent of counties represented after removing cases that 
were attributable to travel. Conversely, exclusion of travel related cases did not result in much 
variability (± 1.8%) among the percentage of counties represented within the choropleth classes 
of 21 to 60 and > 60 confirmed Lyme disease cases. This suggests that counties that reported a 
low number of cases are particularly susceptible to travel related biases. Ultimately, these 
changes in the percent of counties within the case based choropleth classes resulted in 
visualization of two separate maps which were statistically non-equivalent (t = 3.99, df = 54, P = 
0.0002) (Figure 2.1).  
Spatial patterns in the proportion of cases attributable to travel were identified utilizing local 
indicators of spatial autocorrelation. The cluster map (Figure 2.2) displays significant county-
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level clustering in the proportion of cases attributable to travel. The proportion of confirmed 
Lyme disease cases attributable to travel by county are provided as a label over LISA results to 
provide reference to the crude estimates. Counties in western West Virginia and the Eastern 
Panhandle display no significant clustering or clustering of low values of the proportion of cases 
attributable to travel. Alternatively, northern and south central West Virginia counties displayed 
clustering of high proportions with a few spatial outliers with low values neighboring higher 
values. It is important to note that while some counties experienced high proportion of travel 
related cases, not all were denoted as high-high in the LISA cluster map. This discrepancy 
resulted because the value in a given county was high, but was bordered by neighboring counties 
with low proportion of travel related cases (17).  
The choropleth maps and patterns of LISA rankings are consistent with previous research 
regarding travel biases (8) and highlight potential spatial biases which influence consistency of 
non-travel related case reporting due to the combination of low and high incidence states which 
share a border with West Virginia (6).  This spatial bias may be especially relevant in counties 
that form clusters of high proportions of travel-related cases, indicating at-risk areas where Lyme 
disease is not yet endemic, although there are enough travel-related cases that the disease may 
soon spread to these locations. Future research is warranted to incorporate study findings and 
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Figure 2.1 Graphical Representation of the Overall Total and Total Obtained within Patients 







Figure 2.2 Univariate Local Moran’s I with Empirical Bayesian Rate. Numbers within each of 













Using Geo-Analytic Techniques to Evaluate the Utility of Companion Animal Tick 
Surveillance Practices for Monitoring Spread and Occurrence of Human Lyme disease in 
West Virginia, 2014-2016 
 
ABSTRACT 
Companion animals such as dogs and cats are potentially effective sentinel populations for 
monitoring occurrence and spread of Lyme disease. No study to date has evaluated the public 
health utility of sentinel programs using geo-analytic approaches despite the deep-rooted spatial 
processes that influence tick-host disease transmission. Confirmed Lyme disease cases in West 
Virginia and Ixodes scapularis submitted by veterinarians to the state health department were 
obtained for 2014-2016. Separate ordinary least squares and spatial lag regression models were 
conducted to estimate the association between average number of Ixodes scapularis collected on 
pets and human Lyme disease incidence per 1,000 persons.  Residuals from regression models 
were visualized using Local Moran’s I as a diagnostic tool to identify spatial dependence among 
regression models.  Statistically significant associations were identified between average 
numbers of Ix. scapularis collected from dogs and human Lyme disease in the OLS (β=0.20 P < 
0.001) and spatial lag (β = 0.12, P = 0.002) regression. No significant associations were 
identified for cats in either regression model. Statistically significant (P ≤ 0.05) spatial 
dependence was identified in all regression models. Local Moran’s I maps produced for spatial 
lag regression residuals indicated a decrease in model over and underestimation, but identified a 
higher number of statistically significant outliers than OLS regression. Results suggest that dogs 
are effective sentinel populations for monitoring human Lyme disease infection. Findings 
identify significant spatial effects associated with regression residuals, emphasizing the 
36 
 
importance of statistical methodologies, which can accommodate the spatial structure of public 
health surveillance data.   




















Lyme disease is the most commonly reported vectorborne disease in the United States (1, 2). 
Human infection occurs primarily in the Northeastern and North Central United States, but is not 
exclusive to these areas due to constant geographic expansion of the principal vector Ixodes 
scapularis (3, 4). Human risk of exposure is uncertain in many areas where Lyme disease is 
considered an emerging issue due to variability in recognition of infection and disease 
manifestation reported by health officials, biases among diagnostic tests, and insensitivity in 
local tick surveys at early stage invasion (5-7). Tick surveys among companion animals have 
been identified as a potentially representative surveillance methodology for estimating human 
risk within geographic areas where Lyme disease is an emerging concern (8). Animals such as 
dogs, cats, and horses are potentially effective sentinel populations due to increased likelihood of 
tick infestation and close association with their human owners (9). Few studies to date have 
evaluated the utility of companion animal sentinel programs as public health tools with spatial 
analytic approaches to study the spatial structure of tick-host disease transmission dynamics (10). 
Humans and companion animals are dead end hosts for Borrelia burgdorferi, causative agent of 
Lyme disease (11, 12). Exposure to tickborne pathogens occurs when a host comes in contact 
with actively questing ticks in the environment. Presence of infected ticks are influenced by 
environmental factors such as availability of competent reservoir hosts and climatic factors that 
drive tick survival and pathogen propagation (13, 14). Domestic pets, such as dogs, are 
significant risk factors for disease acquisition, and six times more likely to be exposed to infected 
ticks due to the increased potential exposure time in tick habitat (7, 15). Sampling companion 
animal populations is an effective approach to estimate human risk in areas where Lyme disease 
may be newly endemic. 
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Popular concern for Lyme disease has prompted many animal sentinel studies across the United 
States and the United Kingdom (6, 7, 16-19). These studies primarily focused on ticks and 
associated pathogens collected from domestic dogs because of their ability to produce antibodies 
to Borrelia burgdorferi, attainable travel history information, and frequency of outdoor exposure 
(6, 11, 20-24). Methodologies for pathogen detection are restricted to serologic tests such as 
enzyme-linked immunosorbent assay and Western blot, as well as direct polymerase chain 
reaction (PCR) of ticks collected from domestic dogs (6, 7, 16-19). Studies suggest that serology 
screening is an effective approach in Lyme endemic areas (25, 26) but may not be as sensitive an 
indicator for estimating prevalence of infected ticks as direct screening of ticks via PCR within 
areas of low tick density (7). In addition to potential screening biases, previous studies also 
suggest variability in sample size by locality may have influenced study findings (19).  
Some studies have shown that success in detection of Borrelia burgdorferi in dogs or ticks 
collected from dogs correlates with human Lyme disease incidence and tick feeding behavior 
within their respective localities (11, 27). This conclusion, along with recognition that tick 
survival and disease transmission are spatial processes (13), recommend analytic spatial 
approaches to identify areas of increased human risk. To date, no known study has applied 
analytic spatial techniques to investigate geographic associations between Ixodes scapularis 
collected from sentinel companion animal surveillance and human Lyme disease cases, 
investigated sentinel potential for companion animals other than dogs, or employed spatial tools 
to identify areas where increased effort may be needed to optimize Lyme disease surveillance 
efforts. The objectives of our study are to 1) conduct spatial regression to identify geographic 
associations between animal species-specific Ixodes scapularis sentinel and human Lyme disease 
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case data and to 2) investigate local clustering of regression residuals to identify counties were 
additional effort may be needed to optimize surveillance efficacy.  
METHODS  
Study Area 
Annual confirmed human case counts within West Virginia have increased two-fold between 
2005 (n=61) and 2014 (n=136) (3).Geographically, West Virginia is bordered on the east by high 
incidence states of Pennsylvania, Maryland, and Virginia and on the west by the low incidence 
states of Ohio and Kentucky (CDC 2015). In addition to human cases reported, companion 
animal sentinel surveillance data has been collected from local licensed veterinary practices 
within the state since 2013 (28).  
Data acquisition and management 
Human Lyme disease case data in West Virginia were obtained for 2014-2016 from the West 
Virginia state health department (29). Human surveillance data were limited to confirmed cases 
(based on the 2011 Council of State and Territorial Epidemiologists Lyme disease case 
definition) with reported infections acquired within their home county. Restricting raw case 
counts limited biases associated with travel related disease acquisition (30), led to consistency of 
medical, laboratory, and epidemiologic evidence (31), and included recent exposure to tick 
habitat (32). Crude measures of human Lyme disease frequency were calculated by dividing the 
sum of 2014-2016 county-level case counts by 2015 U.S. census West Virginia county-level 




Companion animal surveillance data obtained from the West Virginia state health department 
from 2014-2016 and contained yearly county level information relating the diversity and 
abundance of different tick species removed from animals by veterinarians participating in the 
convenience sample. Sentinel surveillance data requested were limited to 2014-2016, because of 
improved data quality following the initial year of data collection. Observations were sorted by 
county, and Ixodes scapularis removed from animals were summed across individuals in SAS 
9.4.1 (SAS Institute, Cary NC) to produce four variables representing the total and average 
number of Ixodes scapularis collected from dogs and cats by county. All licensed veterinary 
practices within West Virginia received equal opportunity for voluntary participation. Therefore, 
zeros were assigned to any county that had no Ixodes scapularis collection data within our study 
period.  
Human population and case estimates were paired with average number of Ixodes scapularis 
estimates from dogs and cats by respective reporting county in Microsoft Excel. Spreadsheet 
were joined in ArcMap 10.4.1 (ESRI Redlands, CA) to a U.S. Counties and Localities shape file 
obtained U.S. Department of Agriculture National Resources Conservation Service Geospatial 
Gateway (USDA:NRCS) (35).  
Regression and Spatial Analysis 
Separate ordinary least squares regression models were performed using average number of 
Ixodes scapularis collected on dogs and cats as the independent variable and county level human 
Lyme disease incidence per 1,000 as the dependent variable. Rook and queen spatial contiguity 
weights matrices were visualized within connectivity histograms to characterize neighbor 
structures (36). Contiguity based spatial weights were utilized within our spatial analysis to 
satisfy regularity conditions and reduce the potential for introducing heteroscedasticity (37). A 
41 
 
queen contiguity weight was chosen to increase the number of neighbors evaluated during the 
spatial analysis (38). Univariate Local Moran’s I and LISA maps were calculated to identify the 
extent of spatial autocorrelation within the residuals (39). Lagrange multiplier values were 
calculated during the OLS regression utilizing the previously defined queen spatial weights 
matrix, as a model selection tool in comparing spatial lag and error regression models (38, 40). 
Residuals from the spatial model were visualized using univariate Local Moran’s I LISA maps to 
display remaining spatial dependence. Akaike information criterion between OLS and spatial 
autoregressive models were compared to examine model goodness of fit. All regression and 
spatial analyses were conducted in GeoDa 1.8 (GeoDa Center Tempe, AZ).  
RESULTS 
Regression and Spatial Analysis 
County-level incidence of confirmed human Lyme disease ranged between 0-3.88 per 1,000 
persons with an average rate of 0.30 (±0.65) cases per 1,000 persons. County-level Ixodes 
scapularis collections ranged from 0-93 for dogs with a mean number removed of 11.2 (±18.8) 
and 0-37 for cats with a mean number of 5.6 (±9.30). Ordinary least squares regression 
parameters were significant (F = 3.91, P < 0.001) for the dog specific model, and not significant 
(F = 0.91, P = 0.36) for the cat specific model. Univariate Local Moran’s I indicated significant 
clustering among OLS canine (I = 0.27, pseudo P= 0.002) and cat (I = 0.50, pseudo P < 0.001) 
regression residuals. Lagrange multiplier (LM) values were significant for dog spatial lag (F= 
24.0, P < 0.01) and dog spatial error (F = 8.19, P = 0.04) as well as cat spatial lag (F= 30.1, P < 
0.01) and cat spatial error (F = 27.2, P < 0.001) models. Spatial lag autoregressive model was 
chosen based upon higher robust LM values (30.0 vs. 14.0 for dogs and cats (12.8 vs. 9.92) (38), 
and because the spatial lag model adjusts for substantive rather than nuisance spatial dependence 
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(40). Average number of Ixodes scapularis collected per dog remained significant (F = 3.04, P = 
0.002) in the spatial lag model, and identified significant positive spatial dependence (rho = 0.66, 
P < 0.001). Average number of Ixodes scapularis collected per cat remained non-significant (F = 
-0.01, P =0.88) within the spatial lag model. However, a significant (rho = 0.73, P < 0.001) 
strong positive spatial dependence was identified. Univariate Local Moran’s I indicated 
significant dispersal among canine (I = -0.14 pseudo P = 0.02) and non-significant dispersal 
among feline (I = -0.04 pseudo P =0.40) spatial lag residuals. Parameter estimates for animal 
specific regression models are summarized in Table 3.1. Model goodness of fit, measured by a 
reduction in Akaike Information Criterion, was improved for dog (AIC = 76.2 vs. AIC = 98.5) 
and cat (AIC = 84.5 vs. 111.5) models utilizing spatial lag regression. Local indicators of spatial 
autocorrelation (LISA) maps were produced for OLS and spatial lag model residuals for dogs 
and cats (Figure 3.1). High-high ranking indicates counties where human Lyme disease cases per 
1,000 persons are higher than what would be expected after adjusting for covariates. Conversely, 
low, high-low, and low-high rankings indicate counties where human Lyme disease cases per 
1,000 are lower, higher surrounded by lower, or lower surrounded by higher than what would be 
expected after adjusting for covariates. 
DISCUSSION 
Exploratory statistical approaches are routinely applied as methods to evaluate associations 
between animal sentinel and human disease data. This is the first known study to assess 
associations between sentinel surveillance data from dogs and cats and human Lyme disease 
incidence utilizing a combination of ordinary least squares and spatial regression models. 
Significant associations between Ix. scapularis collections from dogs were identified in OLS and 
spatial lag models. This finding is consistent with previous studies which identified dogs as 
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potentially effective sentinel animals for monitoring human Lyme disease due to their close 
association with pet owners, and increased probability for tick exposure (7, 9, 15). Conversely, 
no statistical association was identified between feline Ix. scapularis collections and human 
disease in either OLS or spatial lag autoregressive models. While this may seem unexpected due 
to the similarities in shared exposure risk between domestic cats and dogs, prevalence and 
manifestation of Lyme disease in felines is poorly understood (41).  
Further analysis of model residuals via local indicators of spatial autocorrelation permitted 
additional insight into surveillance system effectiveness by providing a sound diagnostic 
methodology for identifying spatial dependence within the regression models (39, 42). Spatial 
dependence, also termed spatial autocorrelation, results when the assumption of independence 
among dependent variables is violated, or when the regression residuals themselves display 
spatial dependence (42). In either case, parameter estimates from OLS regression are inefficient.  
Local indicators of spatial autocorrelation (LISA) (Figure 1) calculated for OLS regression 
residuals identified significant clustering of model over and underestimation throughout West 
Virginia. Incorporation of the spatial lag model resulted in a reduction in the number of counties 
regarded as high-high (model underestimation) and low-low (model overestimation) among dogs 
and cats. However, residual spatial dependence was identified within spatial lag model residuals 
in the form of low-high and high-low spatial outliers. These spatial outliers are potentially an 
artifact of border bias (36), resulting from a shared border with the Lyme disease endemic states 
of Pennsylvania, Maryland, and Virginia (1). Additionally, they could also be spurious outliers 
resulting from low veterinary participation, and potentially remedied by increasing veterinary 
practice recruitment efforts in West Virginia northeastern panhandle counties.  
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Study findings are based upon a statewide county level ecological regression between human 
Lyme disease incidence per 1,000 persons and animal sentinel data collected as a convenience 
sample from 2014-2016. Spatial lag models are often conducted for data aggregated at the 
county level, but are potentially prone to ecological fallacy if data incorporated are at differing 
spatial scales (37). Additionally, some studies call for the presentation of vector-borne disease 
surveillance data at scales finer than the county level (43). We attempt to adjust for ecological 
fallacy and misclassification biases by incorporating confirmed cases of human Lyme disease 
obtained within patient’s home county of residence and animal sentinel data aggregated at the 
same county level scale. Our analysis was limited to county-level scale as this is the finest scale 
for which travel-associated infection status is noted. Other potential limitations are associated 
with differing reporting biases associated with unequal Lyme disease awareness among 
physicians or other public health officials, and varying presentation of Lyme disease signs and 
symptoms among patients infected (44-46). Unfortunately, we are unable to characterize the 
effect of differing reporting biases due to the aggregate nature of our retrospective investigation.  
Despite these limitations, findings fill significant gaps in the literature regarding the spatial 
biases of public health surveillance data. Results confirm the efficacy of companion animal 
sentinel surveillance programs by further implicating dogs as risk factors for human Lyme 
disease infection. Interestingly, residual spatial dependence was identified among spatial models 
and potentially point to other geographic biases not considered. In particular, West Virginia is 
prone to border biases resulting from shared boundaries with both high and low incidence states 
(1, 36). Results highlight the unique geographic position that West Virginia shares with its 
neighboring states, and emphasize the necessity of spatial analysis to adjust for inherent biases 
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Table 3.1 Summary of Animal Species Specific Regression Results 
Variable Estimate Std. Error P-Value 
Dog Specific Regression Models 
Model 1: Ordinary Least Squares Regression    
Average Ix. scapularis collected 0.20 0.06 < 0.001 
Model 2: Spatial Lag Regression    
Average Ix. scapularis collected 0.12 0.04 0.002 
Average Incidence per 1,000 Persons of Neighboring Counties 0.66 0.10 < 0.001 
 Cat Specific Regression Models 
Model 1: Ordinary Least Squares Regression    
Average Ix. scapularis collected 0.07 0.08 0.36 
Model 2: Spatial Lag Regression    
Average Ix. scapularis collected -0.01 0.55 0.88 























Figure 3.1 Local indicators of spatial autocorrelation maps output from univariate Local 











Mapping of surveillance data has become an increasingly popular method for relaying public 
health information due to the wide availability of geographic information systems. Approaches 
such as disease mapping and cluster analysis have proven useful in public health practice, 
particularly in reference to vectorborne disease (1, 2). Despite the recognition of place in human 
transmission cycles of vectorborne diseases, many studies have yet to characterize geographic 
biases affecting accurate representation of human cases. Our series of three studies were the first 
to identify the effects of boundary and travel related biases on human incidence of Lyme disease 
using ESDA approaches. We then adjust for these biases to increase accuracy of our regression 
models used to investigate associations between companion animal sentinel surveillance 
programs and human Lyme disease incidence. Together the results from these three studies close 
gaps in current knowledge surrounding accurate representation of surveillance data and provide 
the first account of ESDA techniques used to characterize occurrence of human Lyme disease in 
Kentucky, Ohio, and West Virginia. 
Each of our studies were based upon investigation classes within spatial epidemiology with 
careful consideration of cartographic principles to avoid misrepresenting mapped information. 
Our first two investigations were an exercise in disease mapping and cluster analysis, while the 
third was consistent with an ecological analysis. It is important to note that while crude disease 
mapping and cluster analysis are useful in identifying patterns of disease intensity, they lack the 
ability to explain observed patterns (3). Therefore, approaches such as stratification and 
traditional confirmatory statistics were paired with ESDA techniques to provide further 
processing and complementary statistical information to avoid misrepresenting mapped 
information (4). Additionally, identical semiotic displays were employed utilizing the same 
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predefined classes and color schemes to represent LISA cluster map results. Scale for each of the 
studies was limited to the county level because of data availability. While some studies have 
criticized representation of surveillance information at scales as low as the county level (5), data 
on relevant potential confounders were collected no finer than the county-level.  
Even with careful consideration of cartographic principles and pairing of statistical 
methodologies, it is important to note limitations to the project. Findings were based upon 
multiple exploratory spatial analyses of passively collected surveillance data. Therefore, results 
are potentially prone to misclassification bias stemming from inconsistent reporting influenced 
by varying presentation of patient signs and symptoms as well as unequal Lyme disease 
awareness (6-8). Additionally, the decision to designate a case as travel related was based upon 
self-reported travel history and most likely location for exposure. All of these are potentially 
prone to recall bias. Other important considerations are linked to volunteer biases potentially 
influencing the number of veterinary practices participating by county in the companion animal 
surveillance program (9). Unfortunately, we were unable to control for many of these 
information and selection biases due to the retrospective nature of our investigations. 
Despite these limitations, ESDA tools and public health surveillance data offer a practical and 
efficient means to monitor occurrence and spread of disease (10). Overall, project findings: 
1) Indicate a significant increasing time trend in the identification of high-high counties 
of Lyme disease in Maryland, Pennsylvania, Virginia, and West Virginia 
2) Confirm travel associated case inclusion as a confounder of accurate representation of 
mapped Lyme disease surveillance data  
3) Demonstrate the effectiveness of spatial regression models to evaluate the efficacy of 
animal sentinel programs in predicting occurrence of human Lyme disease. 
52 
 
These conclusions are consistent with previous research at the state and national level that 
observed Lyme disease cases clusters at state lines, and hypothesized this to result from 
disproportionate presence of infected ticks, and human behaviors such as travel (3, 11-16). Most 
notably, our findings support previous statements regarding the continually ongoing geographic 
expansion of high-risk Lyme disease designation (10). Future research is warranted to examine 
the extent of geographic influence other potential confounding variables have in accurate 
visualization of human Lyme disease incidence. Additionally, further research is critical to 
understanding the effect of increasing number of collection localities on spatial model efficiency 
for estimating associations between sentinel tick collection methodologies and human Lyme 
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